Artwork

内容由TheBody.com提供。所有播客内容(包括剧集、图形和播客描述)均由 TheBody.com 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

What's so Great About TMC114?

18:19
 
分享
 

Manage episode 127219 series 2246
内容由TheBody.com提供。所有播客内容(包括剧集、图形和播客描述)均由 TheBody.com 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
TheBody.com interviewed Dr. Cal Cohen, one of the lead researchers who investigated TMC114 (darunavir, Prezista) in clinical trials, to get his take on some of the key questions surrounding this new HIV medication: Why should we be so excited about TMC114? What side effects can it cause? How is it likely to change the way HIVers with multidrug resistance are treated?
  continue reading

77集单集

Artwork
icon分享
 
Manage episode 127219 series 2246
内容由TheBody.com提供。所有播客内容(包括剧集、图形和播客描述)均由 TheBody.com 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
TheBody.com interviewed Dr. Cal Cohen, one of the lead researchers who investigated TMC114 (darunavir, Prezista) in clinical trials, to get his take on some of the key questions surrounding this new HIV medication: Why should we be so excited about TMC114? What side effects can it cause? How is it likely to change the way HIVers with multidrug resistance are treated?
  continue reading

77集单集

Wszystkie odcinki

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放